Molica, M., Scalzulli, E., Colafigli, G., Foà, R., & Breccia, M. (2019). Insights into the optimal use of ponatinib in patients with chronic phase chronic myeloid leukaemia. SAGE Publishing.
Chicago Style (17th ed.) CitationMolica, Matteo, Emilia Scalzulli, Gioia Colafigli, Robin Foà, and Massimo Breccia. Insights into the Optimal Use of Ponatinib in Patients with Chronic Phase Chronic Myeloid Leukaemia. SAGE Publishing, 2019.
MLA (8th ed.) CitationMolica, Matteo, et al. Insights into the Optimal Use of Ponatinib in Patients with Chronic Phase Chronic Myeloid Leukaemia. SAGE Publishing, 2019.
Warning: These citations may not always be 100% accurate.